SCI Spotlight

Stanford Cancer Institute members Ash Alizadeh, MD, PhD, and Max Diehn, MD, PhD, have developed several novel techniques for early detection of cancer that rely on blood-based liquid biopsies. 

The overarching goal of the Cancer Therapeutics Program is to foster collaboration across scientific and clinical disciplines in order to gain deeper insights into cancer’s underlying causes and develop more effective diagnostic, prognostic, and therapeutic approaches.

Recognizing the urgent unmet need for treating patients battling advanced melanoma, the Stanford Cancer Institute (SCI) is establishing the Stanford Advanced Melanoma Program—a world-class advanced melanoma center of excellence on the West Coast.

SCI member Marvin Langston, PhD, was recently named a member of the inaugural cohort of Cancer Moonshot Scholars. We spoke with him to learn more about his project that will be funded by the program, his research interests, and what advice he would give students pursuing a career in cancer research.

Since its establishment in 1978, the Stanford Cancer Biology PhD Program has been dedicated to training the next generation of exceptional scientists who will significantly contribute to cancer research.

We spoke to Stanford Cancer Institute member Quynh-Thu Le, MD, about the research she’s most excited about and advice she would give early-career cancer researchers.

The Stanford Cancer Institute Community Advisory Board plays a critical role in ensuring that the SCI meets the needs of our communities by threading our community's diverse perspectives and experiences into the fabric of our initiatives.

The program’s main objective is to provide susceptible communities with the proper melanoma resources and education to catch the disease in its early stages when it is much more treatable.

For those whose thoughts of participating in a cancer clinical trial invoke images of guinea pigs and untested treatments, they may be comforted to learn about the Stanford Cancer Institute’s Scientific Review Committee.

The Canary Center at Stanford is a world-class research facility dedicated to the early detection of cancer under the Department of Radiology. 

The Stanford Cancer Survivorship Program’s mission is to improve the experience and health outcomes of people living with and beyond cancer by advancing survivorship research and access to clinical services and educating healthcare professionals in the science of survivorship care. 

Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. While it is known how this disease takes root, Ravi Majeti, MD, PhD, and the team in the Majeti Lab are looking to tackle it at its source: stem cells.

In the Spotlight

We are proud to feature the voices of cancer research at Stanford, from the bench to the clinic. The SCI Spotlight connects with Stanford cancer researchers and trainees to provide insight into the work we are doing to diagnose, treat, and prevent cancer.  

We are always looking for ways to highlight the accomplishments of our faculty, trainees, and staff. Please contact us if you have any awards or publications you would like us to amplify.